View in EDS

TAK1 signaling is a potential therapeutic target for pathological angiogenesis.

Saved in:
Bibliographic Details
Title: TAK1 signaling is a potential therapeutic target for pathological angiogenesis.
Authors: Zhu L; Menzies Institute for Medical Research, University of Tasmania, 17 Liverpool Street, Hobart, TAS, 7000, Australia.; Department of Ophthalmology, The First Affiliated Hospital of Jinan University, Guangzhou, Guangdong, China., Lama S; Menzies Institute for Medical Research, University of Tasmania, 17 Liverpool Street, Hobart, TAS, 7000, Australia., Tu L; Department of Ophthalmology, The First Affiliated Hospital of Jinan University, Guangzhou, Guangdong, China., Dusting GJ; Centre for Eye Research Australia, Royal Victorian Eye and Ear Hospital, East Melbourne, VIC, Australia.; Ophthalmology, Department of Surgery, University of Melbourne, East Melbourne, VIC, Australia., Wang JH; Centre for Eye Research Australia, Royal Victorian Eye and Ear Hospital, East Melbourne, VIC, Australia., Liu GS; Menzies Institute for Medical Research, University of Tasmania, 17 Liverpool Street, Hobart, TAS, 7000, Australia. rickliu0817@gmail.com.; Ophthalmology, Department of Surgery, University of Melbourne, East Melbourne, VIC, Australia. rickliu0817@gmail.com.; Aier Eye Institute, Changsha, Hunan, China. rickliu0817@gmail.com.
Source: Angiogenesis [Angiogenesis] 2021 Aug; Vol. 24 (3), pp. 453-470. Date of Electronic Publication: 2021 May 10.
Publication Type: Journal Article; Research Support, Non-U.S. Gov't; Review
Journal Info: Publisher: Springer Country of Publication: Germany NLM ID: 9814575 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1573-7209 (Electronic) Linking ISSN: 09696970 NLM ISO Abbreviation: Angiogenesis Subsets: MEDLINE
Database: MEDLINE Ultimate
FullText Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 33973075
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: TAK1 signaling is a potential therapeutic target for pathological angiogenesis.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Zhu+L%22">Zhu L</searchLink>; Menzies Institute for Medical Research, University of Tasmania, 17 Liverpool Street, Hobart, TAS, 7000, Australia.; Department of Ophthalmology, The First Affiliated Hospital of Jinan University, Guangzhou, Guangdong, China.<br /><searchLink fieldCode="AU" term="%22Lama+S%22">Lama S</searchLink>; Menzies Institute for Medical Research, University of Tasmania, 17 Liverpool Street, Hobart, TAS, 7000, Australia.<br /><searchLink fieldCode="AU" term="%22Tu+L%22">Tu L</searchLink>; Department of Ophthalmology, The First Affiliated Hospital of Jinan University, Guangzhou, Guangdong, China.<br /><searchLink fieldCode="AU" term="%22Dusting+GJ%22">Dusting GJ</searchLink>; Centre for Eye Research Australia, Royal Victorian Eye and Ear Hospital, East Melbourne, VIC, Australia.; Ophthalmology, Department of Surgery, University of Melbourne, East Melbourne, VIC, Australia.<br /><searchLink fieldCode="AU" term="%22Wang+JH%22">Wang JH</searchLink>; Centre for Eye Research Australia, Royal Victorian Eye and Ear Hospital, East Melbourne, VIC, Australia.<br /><searchLink fieldCode="AU" term="%22Liu+GS%22">Liu GS</searchLink>; Menzies Institute for Medical Research, University of Tasmania, 17 Liverpool Street, Hobart, TAS, 7000, Australia. rickliu0817@gmail.com.; Ophthalmology, Department of Surgery, University of Melbourne, East Melbourne, VIC, Australia. rickliu0817@gmail.com.; Aier Eye Institute, Changsha, Hunan, China. rickliu0817@gmail.com.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%229814575%22">Angiogenesis</searchLink> [Angiogenesis] 2021 Aug; Vol. 24 (3), pp. 453-470. <i>Date of Electronic Publication: </i>2021 May 10.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article; Research Support, Non-U.S. Gov't; Review
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Springer%22">Springer </searchLink><i>Country of Publication: </i>Germany <i>NLM ID: </i>9814575 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1573-7209 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2209696970%22">09696970 </searchLink><i>NLM ISO Abbreviation: </i>Angiogenesis <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=33973075
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1007/s10456-021-09787-5
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 453
    Titles:
      – TitleFull: TAK1 signaling is a potential therapeutic target for pathological angiogenesis.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Zhu L
      – PersonEntity:
          Name:
            NameFull: Lama S
      – PersonEntity:
          Name:
            NameFull: Tu L
      – PersonEntity:
          Name:
            NameFull: Dusting GJ
      – PersonEntity:
          Name:
            NameFull: Wang JH
      – PersonEntity:
          Name:
            NameFull: Liu GS
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 08
              Text: 2021 Aug
              Type: published
              Y: 2021
          Identifiers:
            – Type: issn-electronic
              Value: 1573-7209
          Numbering:
            – Type: volume
              Value: 24
            – Type: issue
              Value: 3
          Titles:
            – TitleFull: Angiogenesis
              Type: main
ResultId 1